Ceribell (CBLL) Income from Continuing Operations (2023 - 2026)
Ceribell's (CBLL) quarterly Income from Continuing Operations came in at 19737000.0 in Q1 2026, down 54.47% YoY from 43352183.08 in Q1 2025, and down 45.91% on a QoQ basis from 13527000.0 in Q4 2025.
Ceribell (CBLL) Income from Continuing Operations (2023 - 2026) Analysis & Trends
Ceribell (CBLL) has 4 years of Income from Continuing Operations data on file, last reported at 19737000.0 in Q1 2026.
- Quarterly Income from Continuing Operations fell 54.47% year-over-year to 19737000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 60372000.0 (down 35.03% YoY) and the FY2025 annual result came in at 53971000.0, down 69.15% from the prior year.
- Income from Continuing Operations fell to 19737000.0 in Q1 2026, from 13527000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 7054000.0 in Q3 2023 to a low of 19737000.0 in Q1 2026.
- A 4-year average of 11721090.91 and a median of 12576000.0 in 2024 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2025 — Income from Continuing Operations slipped 7.56% — and 2026, when it tumbled 54.47%.
- Tracing CBLL's Income from Continuing Operations over 4 years: stood at 8274000.0 in 2023, then sank by 51.99% to 12576000.0 in 2024, then decreased by 7.56% to 13527000.0 in 2025, then slumped by 45.91% to 19737000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 19737000.0 (Q1 2026), 13527000.0 (Q4 2025), and 13465000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Ceribell | 923.42 Mn | 794.16 Mn | 25.94 Mn | -19.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -19.27 Mn |
| Mar 31, 2026 | -19.74 Mn |
| Dec 31, 2025 | -13.53 Mn |
| Sep 30, 2025 | -13.47 Mn |
| Jun 30, 2025 | -13.64 Mn |
| Mar 31, 2025 | -12.78 Mn |
| Dec 31, 2024 | -12.58 Mn |
| Sep 30, 2024 | -10.42 Mn |
| Jun 30, 2024 | -8.94 Mn |
| Mar 31, 2024 | -8.52 Mn |
| Dec 31, 2023 | -8.27 Mn |
| Sep 30, 2023 | -7.05 Mn |